Ga direct naar de inhoud

Ga direct naar de navigatie

Uitgave van

Farmaceuten werken aan gedragscode voor sector

Farmaceutische bedrijven werken aan een gedragscode die de sector transparanter moet maken. Dat zegt Aarnoud Overkamp, topman van farmaceut Takeda Nederland in een interview in de Volkskrant. Hij is tevens vice-voorzitter van de Vereniging voor Innovatieve Geneesmiddelen die de code opstelt.

Bron: Skipr Nieuws Meer lezen »

LSTM led partnership receives funding to develop drug for treating two neglected tropical diseases

An LSTM led partnership has been awarded nearly £1.5 million from the Medical Research Council for the pre-clinical development of a candidate drug to treat onchocerciasis and lymphatic filariasis, by targeting the bacterial symbiont Wolbachia.

Bron: News-Medical.Net Meer lezen »

U.S. regulator approves Teva migraine drug, shares rise

Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the U.S. Food and Drug Administration (FDA) approved sales of the company’s new migraine treatment, a key drug Teva has been banking on to help revive its fortunes.

Bron: Reuters Health Meer lezen »

Zo maak je met guerrilla marketing je event onvergetelijk

Hoe zorg je ervoor dat bezoekers nog dagen napraten over jouw evenement? Een ijzersterk inhoudelijk programma dat perfect aansluit op de behoeften van je doelgroep is de hoeksteen van elk event. Maar naast de inhoud zijn er nog andere belangrijke ingrediënten voor succes. Denk aan de totaalbeleving, een creatief thema dat de zintuigen prikkelt en een paar verrassende, onvergetelijke elementen waar de mensen over napraten.

Bron: Frankwatching.nl Meer lezen »

Global health regulators find second toxin in common heart drug

European and North American regulators have found a second toxin that may cause cancer in humans in a commonly used blood pressure drug made by Chinese firm Zhejiang Huahai Pharmaceutical Co Ltd.

Bron: Reuters Health Meer lezen »

FDA approves new treatment for people with hairy cell leukemia

AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration has approved LUMOXITI (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

Bron: News-Medical.Net Meer lezen »

Caspase-2 enzyme inhibitor could provide effective way to stop aggressive fatty liver disease

Researchers at University of California San Diego School of Medicine have discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis, a chronic and aggressive liver condition.

Bron: News-Medical.Net Meer lezen »

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients’ immune systems stop the spread of glioblastoma — an aggressive form of brain cancer with very few current treatment options.

Bron: News-Medical.Net Meer lezen »

Dit zijn de marketing & technologie trends van 2019

Eerder deze maand was ik in Cleveland bij Content Marketing World: ‘the one event with the best in contentmarketing’. Goeie trigger om te gaan, dacht ik. Na drie dagen keynotes op zijn Amerikaans (‘OMG did I say I like your shoes?’), marketing vibes en trends zat ik high in het vliegtuig terug naar huis, met een bak aan inspiratie.

Bron: MarketingTribune Meer lezen »

EU officials clash with Chinese firm on drug factory inspection

European medicines regulators have issued a notice that an ingredient for a generic brain cancer drug made in China does not meet manufacturing standards, after inspectors were refused entry to a factory run by Jiangsu Yew Pharmaceutical Co. Ltd.

Bron: Reuters Health Meer lezen »